Management of Functional Dyspepsia
Initial Management Approach
Begin with establishing an empathic doctor-patient relationship and explain that functional dyspepsia is a disorder of gut-brain interaction, then proceed with H. pylori testing and empirical therapy based on symptom pattern. 1
Step 1: Risk Stratification and Appropriate Investigation
Before initiating treatment, determine if urgent investigation is needed:
Patients Requiring Urgent Endoscopy (2-week wait):
- Age ≥55 years with dyspepsia AND weight loss 1
- Age >40 years from high gastric cancer risk area OR family history of gastro-esophageal malignancy 1, 2
Patients Requiring Non-Urgent Endoscopy:
- Age ≥55 years with treatment-resistant dyspepsia 1, 2
- Age ≥55 years with raised platelet count, nausea, or vomiting 1, 2
Patients Requiring Urgent CT Scan:
Baseline Laboratory Testing:
- Full blood count in all patients aged ≥55 years 1, 2
- Coeliac serology in patients with overlapping IBS-type symptoms 1
Step 2: Patient Education and Therapeutic Relationship
Establishing an effective and empathic doctor-patient relationship is fundamental, as this reduces healthcare utilization and improves quality of life. 1
Key Educational Points:
- Explain FD as a disorder of gut-brain interaction, NOT a psychological problem 3, 2
- Discuss the gut-brain axis and how it is impacted by diet, stress, cognitive, behavioral, and emotional responses 1
- Explain the natural history and common symptom triggers 1
- Reassure that most patients with dyspepsia (approximately 80%) will have functional dyspepsia after investigation 1
Step 3: First-Line Pharmacological Management
Test and Treat for H. pylori:
All patients without alarm features should receive non-invasive H. pylori testing (breath or stool test), and if positive, receive eradication therapy. 1, 3, 2
- H. pylori eradication is an effective treatment and prevents future gastroduodenal disease 3, 2
- Confirmation of successful eradication is only necessary in patients at high risk of gastric cancer 1, 3
Empirical Therapy Based on Symptom Pattern:
For Epigastric Pain or Burning (Ulcer-like Dyspepsia):
Prescribe full-dose proton pump inhibitor (PPI) as first-line therapy. 3, 2
- Omeprazole 20 mg once daily is effective and can confirm the acid-related nature of symptoms 3
- Use the lowest dose that controls symptoms, as there is no evidence of dose response 3
For Postprandial Fullness, Early Satiety, or Bloating:
Prescribe a prokinetic agent such as domperidone or itopride as first-line therapy. 3, 2
Common Pitfall:
Do NOT order routine gastric emptying studies or 24-hour pH monitoring in typical functional dyspepsia, as they have low diagnostic yield and delay appropriate treatment. 2, 4
Step 4: Non-Pharmacological Interventions
Recommend regular aerobic exercise for all patients with functional dyspepsia. 3, 2
Advise patients to avoid foods that trigger symptoms. 3
Involve a dietitian early in patients with severe or refractory FD to prevent excessively restrictive diets. 3
Evaluate patients with severe FD who present with weight loss and dietary restriction for eating disorders. 3
Step 5: Management of Refractory Symptoms
If symptoms persist after initial empirical therapy:
Second-Line Options:
- Trial high-dose PPI therapy if not already attempted 2
- Perform endoscopy if not previously done to confirm diagnosis 2
- Consider low-dose tricyclic antidepressants (TCAs) or selective serotonin reuptake inhibitors (SSRIs) for refractory cases 2, 5, 6
Severe or Refractory FD:
Establish a multidisciplinary support team for patients with severe or refractory FD. 3
Consider behavioral therapy, psychotherapy, or antidepressants after reevaluating the diagnosis and providing reassurance. 3, 7
Critical Pitfall:
AVOID opioids and surgery in patients with severe or refractory FD to minimize iatrogenic harm. 3, 2
Step 6: Referral to Gastroenterology
Refer to gastroenterology when there is diagnostic doubt, severe symptoms, refractoriness to first-line treatments, or patient request for specialist opinion. 1
Remember that approximately 20% of dyspepsia patients will have organic disease, so maintain clinical vigilance. 2, 4, 6